沐曦股份启动科创板IPO发行，12月5日进行申购，拟发行4010万股

Core Viewpoint - Muxi Co., Ltd. (688802) is set to launch its initial public offering (IPO) on the Sci-Tech Innovation Board, aiming to raise 3.904 billion yuan for the development of three major GPU projects, positioning itself in the competitive landscape of domestic GPU manufacturers [2][3]. Group 1: IPO Details - The company plans to issue 40.1 million shares, with an initial strategic placement of 8.02 million shares, and the online subscription code is 787802 [2]. - The preliminary inquiry date is set for December 2, 2025, and the subscription date is December 5, 2025 [2]. Group 2: Company Overview - Muxi Co., Ltd. is a leading domestic enterprise in high-performance general-purpose GPU products, focusing on the independent research and development of high-performance GPU chips and computing platforms [3][4]. - The company aims to provide foundational computing power for various sectors, including artificial intelligence, finance, transportation, energy, healthcare, and entertainment [3]. Group 3: Market Position and Performance - Muxi's flagship product, the Xiyun C series GPU chip, is based on fully self-developed GPU IP, instruction set, and architecture, achieving domestic leadership in various performance metrics [4]. - As of the reporting period, Muxi has sold over 25,000 GPU units, with applications in multiple national AI computing power platforms and commercial intelligent computing centers [4]. Group 4: Financial Performance - The company has not yet achieved profitability, with revenues of 53 million yuan, 743 million yuan, and 915 million yuan from 2023 to the first half of 2025, and net losses of 871 million yuan, 1.409 billion yuan, and 186 million yuan during the same period [6]. - Muxi anticipates reaching breakeven by 2026, with cumulative R&D investments of 2.247 billion yuan from 2022 to 2024, representing 282.11% of its revenue [6]. Group 5: Industry Context - The GPU chip industry is characterized by high capital and technology intensity, with significant barriers to entry and substantial R&D investments [7]. - Muxi is positioned as a key player in the "domestic substitution" trend, supported by prominent investors like Sequoia Capital and Matrix Partners, as the industry transitions from "technology validation" to "scale application" [7].